#xec
With the XEC variant on the way to dominance in most places, and XEC waves starting to show in COVID metrics, it is time to ponder which variant will drive the next wave after XEC.

The leading contenders at this point are LP.8.1 and XEC.4.

#COVID19 #XEC #LP_8_1
🧵
December 8, 2024 at 12:49 AM
Here's the latest variant picture for Australia.

XEC.* appears to have taken over dominance from the DeFLuQE variants in mid-November.

XEC.* grew to around 40%.

#COVID19 #Australia #DeFLuQE #XEC
🧵
December 16, 2024 at 2:58 AM
With the XEC variant on the way to dominance in most places, and XEC waves starting to show in COVID metrics, it is time to ponder which variant will drive the next wave after XEC.

Here are the leading contenders: LP.8.1, MC.10.2, MV.1, and XEC.4.

More details:
aus.social/@mike_honey_...
Mike Honey (@mike_honey_@aus.social)
Attached: 1 image With the XEC variant on the way to dominance in most places, and XEC waves starting to show in COVID metrics, it is time to ponder which variant will drive the next wave after XEC. ...
aus.social
November 10, 2024 at 8:53 PM
Here's the latest variant picture with a global scope.

XEC.* variants have been declining slightly, while LP.8.1.* variants grew steadily to around 18%.

#COVID19 #Global #XEC #LP_8_1
🧵
February 22, 2025 at 7:01 AM
With the XEC variant on the way to dominance in most places, it is time to ponder which variant will drive the next wave.

The leading contenders at this point are LP.8.1 and XEC.4.

They are shown here using a log scale, to compare their growth rates vs OG XEC.

#COVID19 #XEC #LP_8_1
🧵
December 1, 2024 at 12:42 PM
Tracking #SARSCoV2 #Lineages - Globally |02/08/25

Top lineages -#30DayTrends #G30

XEC (26.5%)
KP.3.1.1 (7.2%)
LP.8.1.1 (5.6%)
LP.8.1 (4.7%)
MC.1 (4.5%)
XEC.4 (4.5%)
MC.10.1 (4%)
XEC.2 (3.4%)
XEC.8 (2.9%)
XEC.9 (1.9%)

Global Tracker: public.tableau.com/app/profile/...

1/n
February 9, 2025 at 3:25 AM
Here's the latest variant picture for the United States.

XEC.* variants are still dominant, but have fallen to around 34%.

The LP.8.1.* variants have been growing steadily – up to around 24% and on track to take over from XEC.*.

#COVID19 #USA #XEC #LP_8_1
🧵
February 16, 2025 at 12:36 AM
Tracking #SARSCoV2 #Lineages - Globally |02/15/25

Top lineages -#30DayTrends #G30

XEC (24.4%)
LP.8.1.1 (6.8%)
LP.8.1 (6.5%)
KP.3.1.1 (5.1%)
XEC.4 (4.5%)
MC.10.1 (4.2%)
MC.1 (3.7%)
XEC.2 (3.6%)
XEC.8 (3%)
XEC.9 (1.6%)

Global Tracker: public.tableau.com/app/profile/...

1/n
February 16, 2025 at 4:38 AM
Tracking #SARSCoV2 #Lineages - Globally |02/22/25

Top lineages -#30DayTrends #G30

XEC (23.6%)
LP.8.1.1 (8.2%)
LP.8.1 (7.4%)
KP.3.1.1 (5%)
MC.10.1 (4.6%)
XEC.4 (4.2%)
XEC.2 (4.1%)
MC.1 (3.2%)
XEC.8 (2.6%)
XEC.9 (2%)

Global Tracker: public.tableau.com/app/profile/...

1/n
February 23, 2025 at 7:53 AM
Tracking #SARSCoV2 #Lineages - Globally |02/01/25

Top lineages -#30DayTrends #G30

XEC (27.2%)
KP.3.1.1 (8.9%)
MC.1 (4.9%)
LP.8.1.1 (4.3%)
MC.10.1 (4.3%)
XEC.2 (4%)
LP.8.1 (3.9%)
XEC.4 (3.7%)
XEC.8 (1.9%)
XEC.9 (1.8%)

Global Tracker: public.tableau.com/app/profile/...

1/n
February 2, 2025 at 5:56 AM
You down with XEC?
You down with KP.3?
January 16, 2025 at 1:01 PM
Tracking #SARSCoV2 #Lineages - Globally |04/05/25

Top lineages -#30DayTrends #G30

LP.8.1.1 (22%)
XEC (15.3%)
LP.8.1 (12%)
XEC.4 (6%)
MC.10.1 (4.2%)
LF.7 (3.4%)
XEC.2 (2.8%)
LF.7.2.1 (2.6%)
XEC.8 (1.8%)

Global Tracker: public.tableau.com/app/profile/...

1/n
April 6, 2025 at 3:24 AM
Here's the latest variant picture with a global scope, to late March.

Growth of the LP.8.1.* variant resumed to around 38%, with the XEC.* variant declining to 29%.

#COVID19 #Global #XEC #LP_8_1
🧵
April 12, 2025 at 10:17 AM
Tracking #SARSCoV2 #Lineages - Globally |03/29/25

Top lineages -#30DayTrends #G30

LP.8.1.1 (19.5%)
XEC (15.6%)
LP.8.1 (12.5%)
XEC.4 (5.7%)
MC.10.1 (4.3%)
LF.7 (3.9%)
XEC.2 (2.6%)
LF.7.2.1 (2.3%)
XEC.8 (1.8%)

Global Tracker: public.tableau.com/app/profile/...

1/n
March 31, 2025 at 2:02 AM
With the XEC variant on the way to dominance in most places, and XEC waves starting to show in COVID metrics, it is time to ponder which variant will drive the next wave after XEC.

The leading contender at this point is LP.8.1. MC.10.2 and NP.1 seem to have fallen by the wayside.
#COVID19 #XEC
🧵
November 24, 2024 at 8:22 AM
Here's the latest variant picture for the United States, to mid-March.

The LP.8.1.* variant growth resumed, up to around 54%.

The XEC.* variant has declined to around 18%.

#COVID19 #USA #XEC #LP_8_1
🧵
April 12, 2025 at 12:32 PM
Here's the latest variant picture for the United States.

The LP.8.1.* variant has continued to grow steadily to around 37%.

The XEC.* variant continued to fall, down to around 28%.

#COVID19 #USA #XEC #LP_8_1
🧵
March 15, 2025 at 10:51 AM
Here's the latest variant picture for Australia.

The growth of DeFLuQE variants appears to have ended.

XEC.* grew to around 35%.

#COVID19 #Australia #DeFLuQE #XEC @auscovid19@a.gup.pe
🧵
December 7, 2024 at 10:33 PM
Tracking #SARSCoV2 #Lineages - Globally |03/01/25

Top lineages -#30DayTrends #G30

XEC (22.5%)
LP.8.1.1 (9.9%)
LP.8.1 (8.4%)
MC.10.1 (4.6%)
KP.3.1.1 (4.4%)
XEC.2 (4.3%)
XEC.4 (3.4%)
MC.1 (2.5%)
XEC.8 (2.3%)
LF.7 (2%)

Global Tracker: public.tableau.com/app/profile/...

1/n
March 2, 2025 at 5:19 AM
Tracking #SARSCoV2 #Lineages - Globally |01/12/25

Top lineages -#30DayTrends #G30

XEC (30.7%)
KP.3.1.1 (18.6%)
LP.8.1 (5.6%)👀
MC.1 (4.3%)
XEC.2 (4.2%)
MC.10.1 (3%)
XEC.4 (2.3%)
XEK (2.3%)
NP.1 (1.5%)
XEL (1.5%)

Global Trends Tracker: public.tableau.com/app/profile/...

1/n
January 12, 2025 at 8:16 PM
Here's the latest variant picture with a global scope.

The XEC.* variant has continued to decline, while the LP.8.1.* variant grew steadily to around 22%, overhauling the declining JN.1.* + DeFLuQE variants.

#COVID19 #Global #XEC #LP_8_1
🧵
March 1, 2025 at 8:23 AM
Here's the latest variant picture with a global scope.

The DeFLuQE variants remain dominant, but growth appears to have stalled.

Growth of XEC.* has continued, reaching 28%.

#COVID19 #Global #DeFLuQE #XEC
🧵
November 24, 2024 at 3:03 AM
Here's the latest variant picture with a global scope.

XEC.* variants took over dominance from DeFLuQE variants during December, but they are already under pressure.

The LP.8.1.* group of variants have emerged as a challenger, rising steadily to around 10%.

#COVID19 #Global #XEC #LP_8_1
🧵
February 2, 2025 at 10:38 AM
Here's the latest variant picture with a global scope.

XEC.* variants have been declining slightly, while LP.8.1.* variants grew steadily to around 16%.

#COVID19 #Global #XEC #LP_8_1
🧵
February 16, 2025 at 12:18 AM
Here's the latest variant picture for Europe (excluding the UK), to mid-March.

The XEC.* variant remains dominant, but it has declined to around 35% frequency.

The LP.8.1.* variant grew to around 24%.

#COVID19 #EUR #XEC #LP_8_1
🧵
April 13, 2025 at 6:16 AM